Ex-pharma professional will lead DNB’s new biotech fund
DNB Asset Management is launching a new biotech fund later in April, despite the current uncertainty surrounding financial markets. Benedicte Bakke, who has spent most of her career in pharma, will be managing the fund. She tells AMWatch how a dentist ended up in asset management.
BY CAMILLA JENKEY
Which career path did you envision for yourself when you were younger?
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
